Beth Bell
Showing 1–2 of 2 transcripts.
- Milken Institute50 min
Superbugs: Slowing the Spread of Antibiotic-Resistant Bacteria
Maryn McKenna, Beth Bell, Barry Eisenstein, Lance Price, Zachary Rubin
Unchecked antimicrobial resistance threatens to cause 10 million global deaths and $100 trillion in economic losses by 2050, driven by stalled pharmaceutical innovation, agricultural misuse, and rapid pathogen spread. Critical failures in current stewardship and reimbursement models have allowed superbugs like CRE and MCR-1 to emerge, undermining essential medical procedures from cancer treatment to organ transplantation. Urgent interventions including international data sharing, regulatory incentives for novel antibiotics, and a shift in clinical and agricultural practices are now essential to prevent a post-antibiotic era.
- Milken Institute51 min
The 2014 Atlanta Summit - - Race We Can't Afford to Lose: Outsmarting Superbugs
Larry Brilliant, Beth Bell, Victoria Nahum, Lance Price, Andy von Eschenbach
Public health leaders convened to address the critical obsolescence of U.S. disease surveillance technology, which currently lags behind the rapid, cost-effective capabilities of Advanced Molecular Detection required to combat antimicrobial resistance and food-borne threats. Panelists detailed the catastrophic societal costs of preventable infections, including specific cases where delayed diagnostics contributed to mortality, while arguing that federal inaction represents the single greatest immediate risk to national security and public safety. The discussion concluded with a unified call for mandatory antibiotic stewardship, standardized genomic testing, and medical diplomacy to secure global health infrastructure before emerging pathogens outpace current diagnostic limitations.